Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: BRSteve who wrote (1822)	10/23/1998 5:39:00 PM
From: Sigmund	Read Replies (1) \| Respond to of 1894

If someone wants to buy out ACMI rather than buy part or JV with them, I would think that a certain number of classes of investors would have to be satisfied. Sakura et al paid I believe $4.50 per share and some other earlier investors paid quite a bit more. Unless these investors think it is hopeless, they probably would not vote for a deal that was for less than their acquisition cost. But $4.50 is a long way from where we are today so that creates a problem. On the other hand if the stock mysteriously rises to say $2.50 or $3 it would be easier to make such a deal. Is it worth it to anyone? I don't know nor do I know how to assess. After the micro deal is done and if the company allows us to know what the deal was, we will be able to calculate the book value and that might be a factor.